A carregar...
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
Caly et al.(1) reported that ivermectin inhibited severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) in vitro for up to 48 hours using ivermectin at 5 μM. The concentration resulting in 50% inhibition (IC(50); 2 µM) was > 35× higher than the maximum plasma concentration (C(max)) after o...
Na minha lista:
| Publicado no: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267287/ https://ncbi.nlm.nih.gov/pubmed/32378737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1889 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|